Search results for "Inflammatory bowel disease"
Continuing anti-TNF therapy in pregnancy appears beneficial for patients with IBD
A French target trial emulation, which refers to the use of observational data to mimic a randomized controlled trial, found that maternal relapse of inflammatory bowel disease (IBD) and premature births were less common when patients continued anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy than when the drugs were discontinued.
https://gastroenterology.acponline.org/archives/2022/10/28/8.htm
28 Oct 2022
Spotlight on surgical management of IBD
One recent study found that Black patients are at increased risk of morbidity after surgery for inflammatory bowel disease (IBD), while another found benefit of early surgery after diagnosis in certain patients.
https://gastroenterology.acponline.org/archives/2022/10/28/5.htm
28 Oct 2022
MKSAP Quiz: VTE prophylaxis during hospitalization for ulcerative colitis
This month's quiz asks readers to determine the appropriate venous thromboembolism (VTE) prophylaxis in a 30-year-old man hospitalized for an acute flare of ulcerative colitis.
https://gastroenterology.acponline.org/archives/2021/08/27/4.htm
27 Aug 2021
Spotlight on IBD therapy effects
Research in the past month found that infliximab blunts the body's immune response to COVID-19 infection, that both infliximab and adalimumab are effective in long-term treatment of outpatients with inflammatory bowel disease (IBD), and that antitumor necrosis factor therapy may be associated with reduced mortality compared with long-term corticosteroid use in patients with Crohn's disease.
https://gastroenterology.acponline.org/archives/2021/03/26/5.htm
26 Mar 2021
Spotlight on colorectal neoplasia in IBD
Recent research focused on colorectal neoplasia in patients with inflammatory bowel disease (IBD), identifying both risk factors, including a novel association with cigarette smoke exposure, and protective factors.
https://gastroenterology.acponline.org/archives/2021/01/22/5.htm
22 Jan 2021
Cannabis, cannabinoids didn't improve remission or inflammatory markers in IBD
A meta-analysis of inflammatory bowel disease (IBD) studies did find improvements in patient-reported symptoms and quality of life associated with cannabis and cannabinoids.
https://gastroenterology.acponline.org/archives/2020/07/24/3.htm
24 Jul 2020
MKSAP Quiz: Follow-up after a diagnosis of primary sclerosing cholangitis
This month's quiz asks readers to determine the most appropriate management of a 34-year-old patient who presents to follow-up after receiving a diagnosis of primary sclerosing cholangitis.
https://gastroenterology.acponline.org/archives/2022/11/18/4.htm
18 Nov 2022
MKSAP Quiz: A 9-month history of pain, opioids
This month's quiz asks readers to determine the most appropriate management for a patient who has a 9-month history of abdominal pain that has increased with oxycodone use after surgery.
https://gastroenterology.acponline.org/archives/2021/11/19/4.htm
19 Nov 2021
Previous gastroenteritis may be associated with later risk for IBD
In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.
https://gastroenterology.acponline.org/archives/2018/11/27/2.htm
27 Nov 2018
Anti-TNF therapy did not reduce IBD hospitalizations or intestinal resections in Ontario
Infliximab may have been used inappropriately in Crohn's disease and underused in ulcerative colitis, according to the authors of an analysis of hospitalizations, intestinal resections, and drug costs related to inflammatory bowel disease (IBD).
https://gastroenterology.acponline.org/archives/2019/06/28/3.htm
28 Jun 2019